Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-29
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 19
- Registration Number
- NCT06663306
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Strict Weight Management Based on GLP-1 RA for Ablation Outcomes in Overweight or Obese Patients with T2DM and AF
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-10-28
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 174
- Registration Number
- NCT06660134
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-26
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT06659042
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Optimized Posterior Left Atrial Wall Ablation Strategy for PeAF
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-09
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 384
- Registration Number
- NCT06633523
Perioperative Treatment Outcomes of Early NSCLC
- Conditions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT06610240
- Locations
- 🇨🇳
Zhong Hua, Shanghai, Shanghai, China
Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- First Posted Date
- 2024-08-30
- Last Posted Date
- 2024-08-30
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 134
- Registration Number
- NCT06580665
Augmented Reality Assisted Lung Nodule Localization: a Multicentered, Prospective, Randomly Controlled, Non-inferiority Trial
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-12
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 270
- Registration Number
- NCT06548451
- Locations
- 🇨🇳
Jining No. 1 People's Hospital., Jining, China
🇨🇳Shanghai Chest Hospital, Shanghai, Shanghai, China
🇨🇳Zhongshan Hospital, Shanghai, Shanghai, China
Transthoracic vs Transbronchial Ablation for Lung Cancer
- First Posted Date
- 2024-07-16
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT06503744
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 216
- Registration Number
- NCT06483295
- Locations
- 🇨🇳
Zuodong Song, Shanghai, Shanghai, China
Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06483009
© Copyright 2024. All Rights Reserved by MedPath